N-acetylcysteineamide protects against manganese-induced toxicity in SHSY5Y cell line

Yasaswi Maddirala1, Shakila Tobwala1, Nuran Ercal1

  • 1Department of Chemistry, Missouri University of Science and Technology, Rolla, MO 65409, USA.

Brain Research
|February 15, 2015
PubMed

Insights

Manganese (Mn) neurotoxicity causes oxidative stress and mitochondrial dysfunction. The novel antioxidant N-acetylcysteineamide (NACA) protected against Mn-induced damage by scavenging reactive oxygen species and preserving cellular energy.

Area of Science:

  • Neuroscience
  • Toxicology
  • Cell Biology

Background:

  • Manganese (Mn) is essential but toxic at high levels, causing manganism resembling Parkinson's disease.
  • Mn neurotoxicity is linked to oxidative stress and mitochondrial dysfunction.
  • The protective effects of antioxidants against Mn toxicity require further investigation.

Purpose of the Study:

  • To investigate Mn-induced oxidative stress and mitochondrial dysfunction in SHSY5Y neuroblastoma cells.
  • To evaluate the neuroprotective potential of N-acetylcysteineamide (NACA) against Mn toxicity.

Main Methods:

  • Exposure of SHSY5Y cells to Manganese (Mn).
  • Assessment of oxidative stress markers (ROS, GSH, MDA, GR, GPx).
  • Evaluation of mitochondrial function (membrane potential, ATP levels).
  • Analysis of N-acetylcysteineamide (NACA) protective effects.

Main Results:

  • Mn exposure significantly increased reactive oxygen species (ROS) and lipid peroxidation (MDA).
  • Mn altered glutathione (GSH) levels and glutathione reductase/peroxidase activities.
  • Mitochondrial membrane potential loss and decreased ATP levels indicated Mn-induced mitochondrial dysfunction.
  • NACA pretreatment mitigated Mn-induced oxidative stress and preserved mitochondrial function.

Conclusions:

  • Manganese neurotoxicity involves oxidative stress and mitochondrial dysfunction.
  • N-acetylcysteineamide (NACA) demonstrates significant neuroprotective effects against Mn toxicity.
  • NACA shows potential as a therapeutic agent for manganese-induced neurotoxicity.